Entresto 24 MG-26 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DR26F6RA1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,318
Award facts
- Contract value 100% obligated
- $40,317.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Entresto 24 mg-26 mg tablets (180 count) with a contract ceiling value of $40,317.76. This is a firm fixed-price delivery order with no set-aside designation, utilizing open competition. The order is scheduled for completion by November 21, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contract portfolio with the Defense Logistics Agency focused on supplying medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. Entresto, a combination medication used primarily for heart failure treatment, represents one of many pharmaceutical products the company delivers through its prime vendor arrangement. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen as a critical supplier to federal healthcare entities including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26F6RA1?
SPE2DR26F6RA1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F6RA1 worth?
The government has obligated $40,318 on SPE2DR26F6RA1.
Is contract SPE2DR26F6RA1 an order under another contract?
Yes. SPE2DR26F6RA1 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6RA1 competed?
The extent of competition for SPE2DR26F6RA1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award